Ascenta Therapeutics Inc.
This article was originally published in Start Up
Executive SummaryAscenta Therapeutics Inc. thinks it has the right technology and team to make cancer a manageable disease. Its orally bioavailable small molecules are designed to hit key proteins mis-expressed in tumor cells-some of which are the targets of current biologics.
You may also be interested in...
Outsourcing is not just for mundane pharma services anymore. Increasingly, drugmakers are contracting for specialized R&D assistance they expect to provide strategic as well as tactical advantages.